Related Experiment Video

Updated: Aug 29, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Chronic hepatitis C in African Americans and other minority groups

Jaquelyn Fleckenstein1

  • 1Department of Medicine, University of Tennessee, Memphis, 920 Madison Avenue, Suite 200, Memphis, TN 38103, USA. jffleckenste@utmem.edu

Current Gastroenterology Reports
|January 15, 2004
PubMed

Insights

African Americans with chronic hepatitis C virus (HCV) infection show lower treatment response rates and higher rates of hepatocellular carcinoma compared to non-Hispanic whites. Increased diversity in clinical trials is crucial for understanding and addressing these disparities.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Health Disparities

Background:

  • Chronic hepatitis C virus (HCV) is a significant public health concern in the U.S., disproportionately affecting African Americans.
  • African Americans represent a substantial portion of HCV infections and exhibit distinct clinical characteristics and treatment outcomes.
  • Existing research highlights racial disparities in HCV progression and treatment efficacy, necessitating further investigation.

Purpose of the Study:

  • To examine the prevalence and clinical characteristics of chronic hepatitis C virus (HCV) infection among African Americans.
  • To compare treatment response rates and disease progression between African American and non-Hispanic white patients with HCV.
  • To identify factors contributing to observed racial differences in HCV management and outcomes.

Main Methods:

  • Review of epidemiological data on HCV prevalence across racial demographics in the United States.
  • Analysis of clinical studies comparing outcomes of interferon and ribavirin-based therapies in African American versus non-Hispanic white patients.
  • Exploration of immunologic, virologic, and biochemical differences in HCV-infected African American populations.

Main Results:

  • African Americans exhibit a higher prevalence of HCV infection (3.2%) and account for 22% of all U.S. cases.
  • Lower response rates to interferon and ribavirin, including newer regimens like pegylated interferon and ribavirin, are observed in African Americans.
  • African Americans show a lower likelihood of cirrhosis but a higher risk of hepatocellular carcinoma and a higher prevalence of genotype 1 infection.

Conclusions:

  • Significant racial disparities exist in chronic hepatitis C virus (HCV) infection outcomes and treatment efficacy between African Americans and non-Hispanic whites.
  • Underrepresentation of minority groups, including Mexican Americans, in clinical trials limits understanding of HCV in diverse populations.
  • Ongoing efforts to enhance racial diversity in clinical trials are essential for equitable HCV research and patient care.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...